نتایج جستجو برای: differentiated chondrosarcoma

تعداد نتایج: 62783  

Journal: :PPAR Research 2008
K. Nishida T. Kunisada Z. N. Shen Y. Kadota K. Hashizume T. Ozaki

Induction of differentiation and apoptosis in cancer cells by ligands of PPARgamma is a novel therapeutic approach to malignant tumors. Chondrosarcoma (malignant cartilage tumor) and OUMS-27 cells (cell line established from grade III human chondrosarcoma) express PPARgamma. PPARgamma ligands inhibited cell proliferation in a dose-dependent manner, and induced apoptosis of OUMS-27. The higher-g...

2016
Ju-Fang Liu Chien-Yu Chen Hsien-Te Chen Chih-Shiang Chang Chih-Hsin Tang

Chondrosarcoma is a highly malignant cartilage-forming bone tumor that has the capacity to invade locally and cause distant metastasis. Moreover, chondrosarcoma is intrinsically resistant to conventional chemotherapy or radiotherapy. The novel benzofuran derivative, BL-038 (2-amino-3-(2,6-dichlorophenyl)-6-(4-methoxyphenyl)benzofuran-4-yl acetate), has been evaluated for its anticancer effects ...

2012
Thivi Vasilakaki Aikaterini Tsavari Evangelia Skafida Kalliroi Koulia Despina Myoteri Xanthipi Grammatoglou Alexandra Zisi Nikolaos Firfiris Kassiani Manoloudaki

INTRODUCTION Cartilaginous tumors involving the small bones of the hands and feet are usually benign such as enchondroma, chondromyxoid fibroma and chondroblastoma. The small bones of the hands and feet are rarely involved by primary chondrosarcoma. Proximal phalanges are the most common sites in the hands, but the fourth digit is the least common site. CASE PRESENTATION We report a case of a...

2013
Chih-Yang Lin Hui-Jye Chen Te-Mao Li Yi-Chin Fong Shan-Chi Liu Po-Chun Chen Chih-Hsin Tang

Chondrosarcoma is a primary malignant bone cancer, with a potent capacity to invade locally and cause distant metastasis; it has a poor prognosis and shows a predilection for metastasis to the lungs. Brain derived neurotrophic factor (BDNF) is a small-molecule protein from the neurotrophin family of growth factors that is associated with the disease status and outcomes of cancers. However, the ...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2013
Yi-Xiang Zhang Jolieke G van Oosterwijk Ewa Sicinska Samuel Moss Stephen P Remillard Tom van Wezel Claudia Bühnemann Andrew B Hassan George D Demetri Judith V M G Bovée Andrew J Wagner

PURPOSE Chondrosarcomas are notoriously resistant to cytotoxic chemotherapeutic agents. We sought to identify critical signaling pathways that contribute to their survival and proliferation, and which may provide potential targets for rational therapeutic interventions. EXPERIMENTAL DESIGN Activation of receptor tyrosine kinases (RTK) was surveyed using phospho-RTK arrays. S6 phosphorylation ...

2017
Supreeth Nekkanti Ravi Kiran

Introduction Myxoid chondrosarcoma is a distinct subtype of chondrosarcoma with several key differences from conventional chondrosarcoma of bone. Our review of the literature and have found that myxoid chondrosarcoma is typically extra skeletal in presentation. Very few cases of myxoid chondrosarcoma of the hand or wrist have been reported and they were extra skeletal in presentation [1-10]. We...

2018
Daigo Kojima Takaaki Beppu Hiroaki Saura Yuichi Sato Shunrou Fujiwara Kuniaki Ogasawara

Intracranial chondrosarcoma is a very rare malignant tumor of the central nervous system, and is difficult to preoperatively distinguish from other tumors using conventional imaging techniques. Here, we report the case of a 24-year-old woman who presented with mild headache due to chondrosarcoma in the frontal lobe. Preoperative conventional images showed findings typical of an oligodendroglial...

2017
Kentaro Miyamoto Bisei Ohkawara Mikako Ito Akio Masuda Akihiro Hirakawa Tadahiro Sakai Hideki Hiraiwa Takashi Hamada Naoki Ishiguro Kinji Ohno

Abnormal activation of the Wnt/β-catenin signaling is implicated in the osteoarthritis (OA) pathology. We searched for a pre-approved drug that suppresses abnormally activated Wnt/β-catenin signaling and has a potency to reduce joint pathology in OA. We introduced the TOPFlash reporter plasmid into HCS-2/8 human chondrosarcoma cells to estimate the Wnt/β-catenin activity in the presence of 10 μ...

Journal: :Vestnik travmatologii i ortopedii imeni N.N. Priorova 2022

BACKGROUND: Malignant neoplasms with lesions of the chest are quite rare in sternum and range from 0.5 to 3.1% total number patients bone tumors all localizations. In this connection, there few publications describing tactics surgical treatment methods prosthetics formed defect. The present article describes a clinical case successful application an individual prosthesis manubrium G1 chondrosar...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید